Neurohemodynamic correlates of BDNF gene expression in schizophrenia patients with working memory deficits: A functional MRI study.


Journal

Asian journal of psychiatry
ISSN: 1876-2026
Titre abrégé: Asian J Psychiatr
Pays: Netherlands
ID NLM: 101517820

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 13 05 2022
revised: 18 08 2022
accepted: 14 09 2022
pubmed: 2 10 2022
medline: 19 10 2022
entrez: 1 10 2022
Statut: ppublish

Résumé

Brain-derived neurotrophic factor (BDNF) is involved in neuroplasticity underlying cognitive deficits, including working memory deficits (WMD), in schizophrenia. Methodological challenges and inconsistencies are reported with peripheral BDNF levels. Left dorsolateral prefrontal cortex (DLPFC) is proposed to underlie WMD, though inconsistently. We aimed to explore the correlations between brain activation during working memory task-based functional Magnetic Resonance Imaging (fMRI) and BDNF gene expression in schizophrenia patients with WMD. 26 patients with schizophrenia with established WMD were recruited for the study. Blood samples were collected to study lymphocyte BDNF gene expression. Patients underwent task-based fMRI to examine the working memory performance and related brain activation. Whole-brain analysis was performed with 2-back > 0-back and 2-back > rest contrast. The peak intensity values of the activation were used for correlation analysis. Whole brain analysis with 2-back > rest contrast revealed maximum activation in left DLPFC, Brodmann area 9 (t = 10.54, FWE corrected p < 0.05). The baseline BDNF gene expression correlated positively with the peak intensity of brain activation in left DLPFC (r = 0.365, p = 0.033). Negative symptom score negatively correlated with BDNF gene expression (r = -0.499, p = 0.005) and left DLPFC fMRI activation (r = -0.393, p = 0.023) respectively. We found a significant positive association between BDNF gene expression and the activation of the DLPFC during the working memory task. This novel observation needs further systematic evaluation to establish the potential role of peripheral BDNF expression in WMD in schizophrenia.

Identifiants

pubmed: 36181754
pii: S1876-2018(22)00259-3
doi: 10.1016/j.ajp.2022.103261
pii:
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
BDNF protein, human 7171WSG8A2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103261

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All the authors assure that there are no commercial or financial involvements that might present an appearance of a conflict of interest in connection with this article.

Auteurs

Sowmya Selvaraj (S)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India. Electronic address: sowmya.nimhans@gmail.com.

Venkataram Shivakumar (V)

Department of Integrative Medicine, National Institute of Mental Health And Neurosciences, Bangalore, India.

Paranthaman V Kavya (PV)

Department of Human Genetics, National Institute of Mental Health And Neurosciences, Bangalore, India.

Thrinath Mullapudi (T)

Department of Human Genetics, National Institute of Mental Health And Neurosciences, Bangalore, India.

Gaurav Bhalerao (G)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Vanteemar S Sreeraj (VS)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Satish Suhas (S)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Damodharan Dinakaran (D)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Rujuta Parlikar (R)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Harleen Chhabra (H)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Janardhanan C Narayanaswamy (JC)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Monojit Debnath (M)

Department of Human Genetics, National Institute of Mental Health And Neurosciences, Bangalore, India.

Naren P Rao (NP)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Kesavan Muralidharan (K)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Ganesan Venkatasubramanian (G)

Department of Psychiatry, National Institute of Mental Health And Neurosciences, Bangalore, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH